Serum Hepcidin Level in Patients with Acute Lymphoblastic Leukemia (ALL) during The Treatment Phase: Their Effects on Erythropoisis Activity and Iron Reserves

I Wande and Yetti Hernaningsih and Ketut Ariawati and Paulus Budiono Notopuro and Ni Made Linawati and Pande Putu Ayu Patria Dewi (2020) Serum Hepcidin Level in Patients with Acute Lymphoblastic Leukemia (ALL) during The Treatment Phase: Their Effects on Erythropoisis Activity and Iron Reserves. International Journal of Pharmaceutical Research, 12 (3). pp. 2304-2307. ISSN 09752366

[img] Text (Artikel)
Serum Hepcidin.pdf

Download (389kB)
[img] Text (Peer Review)
Serum Hepcidin Level in Patients with Acute Lymphoblastic Leukemia (AAL) during The Treatment Phase Their Effects on Erythropoisis Activity and Iron Reserve.pdf

Download (1MB)
[img] Text (Similarity)
Serum Hepcidin Level in Patients with Acute Lymphoblastic Leukemia (ALL) during The Treatment Phase Their Effects on Erythropoisis Activity and Iron Reserves.pdf

Download (896kB)
[img] Text (Bukti Etik)
Bukti Etik Serum Hepcidin.pdf

Download (212kB)
Official URL: http://www.ijpronline.com/ViewArticleDetail.aspx?I...

Abstract

Hepcidin levels increased significantly with increased of iron stores in early phase of acute leukemia patients when erithropoisis pressed by blast cells in bone marrow, then decreased significantly with acute leukemia remission. The study aimed to determine role of hepcidin in activity of erythropoisis and serum iron reserves in acute lymphoblastic leukemia (ALL) patients during phase of therapy. This study used an observational analytic design. Serum hepcidin examination used ELISA methods. Erythropoisis activity was determined by complete blood and reticulocyte percentage. Iron reserves was determined by serum iron and ferritin levels by ECLIA. Result shows a total of 48 patient subjects were divided into groups of induction, consolidation and maintenance phase with an average age of 6.81 years (induction), 9.7 years (consolidation) and 7.8 years (maintenance). In the normality test with Shapiro-Wilk data showed abnormal distribution (p <0.05). Analysis by the Kruskal-Wallis test showed there were differences between the three treatment phases in the examination of hemoglobin, reticulocytes, serum iron, ferritin and hepcidin (p <0.05). In statistical analysis with Spearman's rank correlation shows there is a significant correlation between hemoglobin with ferritin (r = -0.416, p = 0.003), hemoglobin with hepcidin (r = -0.305, p = 0.035), reticulocytes with hepcidin (r = -0.496), p = 0.000) and serum iron with hepcidin (r = -0.302, p = 0.037). We concluded that the higher levels of hepcidin indicate lower levels of hemoglobin, reticulocytes and serum iron in patients with acute lymphoblastic leukemia during treatment phase.

Item Type: Article
Uncontrolled Keywords: Hepcidin, Acute Lymphoblastic Leukemia, Erythropoisis
Subjects: R Medicine > R Medicine (General)
R Medicine > RB Pathology > RB37-56.5 Clinical pathology. Laboratory technique
Divisions: 01. Fakultas Kedokteran > Patologi Klinik
Creators:
CreatorsNIM
I WandeUNSPECIFIED
Yetti HernaningsihNIDN0020127307
Ketut AriawatiUNSPECIFIED
Paulus Budiono NotopuroNIDN0005057711
Ni Made LinawatiUNSPECIFIED
Pande Putu Ayu Patria DewiUNSPECIFIED
Depositing User: arys fk
Date Deposited: 06 May 2021 05:43
Last Modified: 06 May 2021 05:43
URI: http://repository.unair.ac.id/id/eprint/106359
Sosial Share:

Actions (login required)

View Item View Item